Literature DB >> 11479623

Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory.

D Homann1, L Teyton, M B Oldstone.   

Abstract

Emerging evidence indicates that CD8+ and CD4+ T-cell immunity is differentially regulated. Here we have delineated differences and commonalities among antiviral T-cell responses by enumeration and functional profiling of eight specific CD8+ and CD4+ T-cell populations during primary, memory and recall responses. A high degree of coordinate regulation among all specific T-cell populations stood out against an approximately 20-fold lower peak expansion and prolonged contraction phase of specific CD4+ T-cell populations. Surprisingly, although CD8+ T-cell memory was stably maintained for life, levels of specific CD4+ memory T cells gradually declined. However, this decay, which seemed to result from less efficient rescue from apoptosis, did not affect functionality of surviving virus-specific CD4+ T cells. Our results indicate that CD4+ T-cell memory might become limiting under physiological conditions and that conditions precipitating CD4+ T-cell loss might compromise protective immunity even in the presence of unimpaired CD8+ T-cell responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11479623     DOI: 10.1038/90950

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  237 in total

Review 1.  T cell responses to viral infections: lessons from lymphocytic choriomeningitis virus.

Authors:  Aaruni Khanolkar; Michael J Fuller; Allan J Zajac
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 2.  The role of mTOR in memory CD8 T-cell differentiation.

Authors:  Koichi Araki; Ben Youngblood; Rafi Ahmed
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

3.  Bacterial superantigen exposure after resolution of influenza virus infection perturbs the virus-specific memory CD8(+)-T-cell repertoire.

Authors:  Chiu-Chen Huang; Sangeeta Shah; Phuong Nguyen; John D Altman; Marcia A Blackman
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

4.  Subsets of memory cytotoxic T lymphocytes elicited by vaccination influence the efficiency of secondary expansion in vivo.

Authors:  Michael S Seaman; Fred W Peyerl; Shawn S Jackson; Michelle A Lifton; Darci A Gorgone; Jörn E Schmitz; Norman L Letvin
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

Review 5.  Ligand-dependent regulation of T cell development and activation.

Authors:  Ronald N Germain
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

6.  Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function.

Authors:  Amy D H Doody; Joseph T Kovalchin; Marianne A Mihalyo; Adam T Hagymasi; Charles G Drake; Adam J Adler
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

7.  Division-linked generation of death-intermediates regulates the numerical stability of memory CD8 T cells.

Authors:  Jeffrey C Nolz; Deepa Rai; Vladimir P Badovinac; John T Harty
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

Review 8.  Nature and nurture: T-cell receptor-dependent and T-cell receptor-independent differentiation cues in the selection of the memory T-cell pool.

Authors:  Chulwoo Kim; Matthew A Williams
Journal:  Immunology       Date:  2010-08-25       Impact factor: 7.397

9.  CD4+ T cell persistence and function after infection are maintained by low-level peptide:MHC class II presentation.

Authors:  Ryan W Nelson; James B McLachlan; Jonathan R Kurtz; Marc K Jenkins
Journal:  J Immunol       Date:  2013-02-04       Impact factor: 5.422

10.  Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers.

Authors:  Cheryl L Day; Nilufer P Seth; Michaela Lucas; Heiner Appel; Laurent Gauthier; Georg M Lauer; Gregory K Robbins; Zbigniew M Szczepiorkowski; Deborah R Casson; Raymond T Chung; Shannon Bell; Gillian Harcourt; Bruce D Walker; Paul Klenerman; Kai W Wucherpfennig
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.